Find a Clinical Trial

Is a clinical trial right for you? Search our database to find studies for which you may be eligible.

Browse All Clinical Trials

Viewed View Trial

Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE

Study Type: Prevention

Phase: N/A

NCTID: NCT04905069

Principal Investigator: Ronald Chen

Viewed View Trial

Phase III Study, CONTACT-02: A Phase III, Randomized, Open-Label, Controlled Study of Cabozantinib XL 184 in Combination with Atezolizumab vs Second Novel Hormonal Therapy NHT in Subjects with Metastatic Castration-Resistant Prostate Cancer

Study Type: Treatment

Phase: III

NCTID: NCT04446117

Principal Investigator: Rahul Parikh

Viewed View Trial

A Phase III, Multi-center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Men with Biochemical Recurrence of Prostate Cancer

Study Type: Diagnostic

Phase: III

NCTID: NCT06235099

Principal Investigator: William Parker

Viewed View Trial

A Phase I Dose Escalation and Expanded Cohort Study of Pf-06821497 in the Treatment of Adult Patients with Relapsed/Refractory Small Cell Lung Cancer SCLC, Castration Resistant Prostate Cancer CRPC and Follicular Lymphoma FL

Study Type: Treatment

Phase: I

NCTID: NCT03460977

Principal Investigator: Joaquina Baranda

Viewed View Trial

A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events MACEs in Patients with Prostate Cancer and Cardiovascular Disease Receiving Degarelix GnRH Receptor Antagonist or Leuprolide GnRH Receptor Agonist

Study Type: Treatment

Phase: III

NCTID: NCT02663908

Principal Investigator: Moben Mirza

Viewed View Trial

A Phase II Study of M1774 in Refractory SPOP-Mutant Prostate Cancer

Study Type: Treatment

Phase: II

NCTID: NCT05828082

Principal Investigator: Rahul Parikh

Viewed View Trial

A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study ICON study number: 0798/0661

Study Type: Treatment

Phase: II

NCTID: NCT02960022

Principal Investigator: Rahul Parikh

Viewed View Trial

A Phase I Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients with Metastatic Castration Resistant Prostate Cancer

Study Type: Treatment

Phase: I

NCTID: NCT04227275

Principal Investigator: Rahul Parikh

Viewed View Trial

A Phase II Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer

Study Type: Treatment

Phase: II

NCTID: NCT05005728

Principal Investigator: Rahul Parikh

Viewed View Trial

A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer COMPPARE

Study Type: Treatment

Phase: N/A

NCTID: NCT03561220

Principal Investigator: Xinglei Shen